If you enjoy this content, please share it with a colleague
Philips
RELATED CONTENT
According to an industry market report released by Mordor Intelligence in May 2018, the computed tomography (CT) market ...
Philips announced what it calls its ultimate ultrasound solution for breast assessment, available with the Philips Epiq and Affiniti ultrasound systems, and the combination of the eL18-4 transducer and anatomical intelligence. This all-in-one solution brings together high-quality imaging with complementary clinical tools tailored for breast screenings. With the new breast solution, clinicians can efficiently assess, monitor and treat breast diseases, increasing diagnostic confidence and helping to improve patient care.
Carri Glide-Hurst, Ph.D., director of translational research, radiation oncology at Henry Ford Health System, describes ...
When Cullman Regional Medical Center in Alabama decided to switch from 2-D to 3-D mammography, they knew they needed to ...
At the Transcatheter Cardiovascular Therapeutics (TCT) annual meeting, Sept. 21–25 in San Diego, Philips is showcasing its latest solutions in interventional cardiology. These solutions combine imaging systems, planning and navigation software, and specialized diagnostic and therapeutic devices, helping clinicians conduct procedures that are fast, efficient and personalized.
September 14, 2018 — Philips announced the launch of the Ingenia Ambition X 1.5T magnetic resonance imaging (MRI) scanne ...
As soon as the Compressed SENSE technology became available to the MRI team at Kantonsspital Winterthur (Switzerland), the site started applying the acceleration possibilities for their MRI scans of the brain, spine and joints, as well as pelvis and abdomen. Using Compressed SENSE appeared a simple yet powerful way to accelerate MRI scanning for different contrast types and sequences, in 2-D as well as 3-D. The significantly reduced scan times convinced the team to plan for adjusting all their ExamCards, with the objective to shorten patient timeslots and then actually plan for increasing their number of MRI patients per day. This is of strategic importance to help them generate revenue when reimbursements go down.
Nuclear imaging technology for both single photon emission computed tomography (SPECT) and positron emission tomography (PET) have made advancements in the past couple years. The main drivers for this have been a movement to digital imaging detectors to improve image quality and address radiation dose concerns, reimbursement and radiotracer supply issues. Other advancements have come in the areas of software to improve image reconstruction quality, offer better clinical qualification and analytics data.
Philips recently announced the introduction of the Epiq CVx cardiovascular ultrasound system. Built on the Epiq ultrasound platform, Epiq CVx is specifically designed to increase diagnostic confidence and simplify workflow for clinicians, giving them more time to interact with their patients and reducing the need for repeat scans. According to Philips, 95 percent of a group of clinicians who were shown the new system believed it offered improved image quality: sharper and clearer images [1]. Philips is also introducing the Epiq CVxi, specifically tailored for use in the interventional lab. Both systems are CE marked and have received 510(k) clearance from the U.S. Food and Drug Administration (FDA).
Intel and Philips recently tested two healthcare uses for deep learning inference models using Intel Xeon Scalable processors and the OpenVINO toolkit. One use case focused on X-rays of bones for bone-age-prediction modeling, the other on computed tomography (CT) scans of lungs for lung segmentation. In these tests, Intel and Philips achieved a speed improvement of 188 times for the bone-age-prediction model, and a 38 times speed improvement for the lung-segmentation model over the baseline measurements.
November 05, 2018 